1. Home
  2. NKTR vs LZB Comparison

NKTR vs LZB Comparison

Compare NKTR & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$36.98

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

HOLD

Current Price

$29.78

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTR
LZB
Founded
1990
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1996
1994

Fundamental Metrics

Financial Performance
Metric
NKTR
LZB
Price
$36.98
$29.78
Analyst Decision
Buy
Buy
Analyst Count
15
2
Target Price
★ $133.08
$41.00
AVG Volume (30 Days)
★ 1.4M
534.4K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
★ 3.18%
EPS Growth
N/A
★ 5.11
EPS
N/A
★ N/A
Revenue
$307,711,000.00
★ $2,349,433,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.00
$3.50
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 86.00
N/A
52 Week Low
$33.40
$28.39
52 Week High
$109.00
$44.90

Technical Indicators

Market Signals
Indicator
NKTR
LZB
Relative Strength Index (RSI) 29.12 46.72
Support Level $34.45 $28.79
Resistance Level $39.59 $30.84
Average True Range (ATR) 1.98 0.76
MACD 0.66 0.19
Stochastic Oscillator 22.11 56.53

Price Performance

Historical Comparison
NKTR
LZB

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.

Share on Social Networks: